|
KIAA2018 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.21880000431207E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.55359999987459E-07 |
| Normal-vs-Stage2 |
1.807910E-04 |
| Normal-vs-Stage3 |
2.55059995346585E-09 |
| Normal-vs-Stage4 |
1.1575000002928E-07 |
| Stage1-vs-Stage2 |
8.821200E-01 |
| Stage1-vs-Stage3 |
4.980100E-02 |
| Stage1-vs-Stage4 |
5.750500E-02 |
| Stage2-vs-Stage3 |
2.151200E-01 |
| Stage2-vs-Stage4 |
2.163800E-01 |
| Stage3-vs-Stage4 |
8.758400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.26450000365242E-09 |
| Normal-vs-AfricanAmerican |
9.801900E-03 |
| Normal-vs-Asian |
2.48049999999056E-05 |
| Caucasian-vs-AfricanAmerican |
3.249200E-01 |
| Caucasian-vs-Asian |
8.445800E-01 |
| AfricanAmerican-vs-Asian |
4.478600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.01709995770483E-09 |
| Normal-vs-Female |
4.83159999786764E-08 |
| Male-vs-Female |
2.279000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.73257999999121E-05 |
| Normal-vs-Age(41-60Yrs) |
4.67350003141576E-09 |
| Normal-vs-Age(61-80Yrs) |
1.30690000044176E-07 |
| Normal-vs-Age(81-100Yrs) |
2.999800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.584570E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.713050E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.907200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.001600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.785800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.596000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.555600E-02 |
| Classical-VS-Follicular |
7.329800E-02 |
| Classical-VS-Other |
1.348820E-01 |
| Classical-VS-Normal |
7.87900000021047E-07 |
| Tall-VS-Follicular |
5.743400E-01 |
| Tall-VS-Other |
4.516600E-01 |
| Tall-VS-Normal |
5.91810000005744E-07 |
| Follicular-VS-Other |
3.787600E-01 |
| Follicular-VS-Normal |
2.04979999973709E-07 |
| Other-VS-Normal |
2.637800E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.49729999510129E-08 |
| Normal-vs-N1 |
9.46420000036419E-07 |
| N0-vs-N1 |
5.525400E-01 |
|
|
